Form 4: Pacira BioSciences Chief Administrative Officer Reports Stock Sales Following RSU Vesting

Pacira BioSciences' Chief Administrative Officer, Kristen Williams, reported the sale of 14,376 shares of common stock and the withholding of 6,162 shares for tax obligations, reducing her beneficial ownership to 161,574 shares.

Summary

• Kristen Williams, Chief Administrative Officer of Pacira BioSciences, Inc. (PCRX), filed a Form 4 detailing changes in her beneficial ownership.
• On June 3, 2025, 6,162 shares of common stock were disposed of at a price of $26.4 per share. This transaction was coded 'F', indicating shares withheld by the issuer to cover tax withholding obligations upon the vesting of a restricted stock unit (RSU) award.
• Following this tax-related disposition, Kristen Williams beneficially owned 175,950 shares of common stock.
• On June 4, 2025, an additional 14,376 shares of common stock were sold at a price of $26.24 per share. This transaction was coded 'S', indicating a direct sale.
• After both reported transactions, Kristen Williams' beneficial ownership of Pacira BioSciences common stock stands at 161,574 shares.

Sentiment

Score: 5

Explanation: The document reports routine insider transactions, including tax-related withholding and a direct sale, which are common following RSU vesting. It does not inherently signal strong positive or negative sentiment about the company's future performance or prospects.

Positives

• The reporting person, a Chief Administrative Officer, continues to hold a significant number of shares (161,574), indicating ongoing alignment with shareholder interests.

Negatives

• An insider sale of 14,376 shares, even if routine, can sometimes be perceived negatively by the market, though this specific sale is relatively small in the context of total shares outstanding.

Future Outlook

This Form 4 filing is a report of past insider transactions and does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing is a routine insider transaction report common across all publicly traded companies, reflecting an executive's management of their equity compensation. It does not provide specific insights into broader industry trends within the biosciences sector.

Related Party Transactions

• The transactions involve an executive (Kristen Williams, Chief Administrative Officer) and the issuer (Pacira BioSciences, Inc.), which are considered related parties in the context of insider trading regulations.

Stakeholder Impact

• Shareholders: The sale of shares by an executive could be interpreted in various ways, but given the context of RSU vesting and tax obligations, it is unlikely to have a significant negative impact on shareholder confidence. The executive retains a substantial holding.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Recommendation

Keywords

Pacira BioSciences, PCRX, Form 4, Insider Trading, Stock Sale, Restricted Stock Units, RSU Vesting, Kristen Williams, Chief Administrative Officer, Beneficial Ownership